Insider · CIK 0001218815
Herbert J Conrad
Files at CLDX (Celldex Therapeutics, Inc.). First filing -, latest -.
Herbert J Conrad files SEC Form 4 as director at CLDX (Celldex Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Herbert J Conrad has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | CLDX Celldex Therapeutics, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 29, 2026 |
| Jun 5, 2025 | CLDX Celldex Therapeutics, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +16,500 | $0.00 | $0 | 16,500 | Jun 9, 2025 |
Questions about Herbert J Conrad
Answered from the filings on this page, as of the latest one.
Is Herbert J Conrad buying or selling?
Herbert J Conrad has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Herbert J Conrad's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Herbert J Conrad has 0.
Where does Herbert J Conrad file Form 4?
Herbert J Conrad has filed Form 4 at CLDX (Celldex Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.